Gqg Partners LLC Novo Nordisk A S Transaction History

Gqg Partners LLC

$63.6 Billion
Q3 2024

A detailed history of Gqg Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gqg Partners LLC holds 7,438,073 shares of NVO stock, worth $632 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

7,438,073

Previous 4,214,216 76.5%

Holding current value

$632 Million

Previous $602 Million 47.23%

% of portfolio

1.39%

Previous 0.92%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $384 Million - $469 Million	3,223,857 Added 76.5%	7,438,073 $886 Million
Q2 2024 Aug 12, 2024	BUY	$122.71 - $146.91 $71.3 Million - $85.4 Million	581,152 Added 16.0%	4,214,216 $602 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $322 Million - $428 Million	3,151,584 Added 654.56%	3,633,064 $466 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $6.61 Million - $7.95 Million	75,344 Added 18.55%	481,480 $49.8 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $19.2 Million - $42.2 Million	211,591 Added 108.76%	406,136 $36.9 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $4.62 Million - $5.11 Million	-29,616 Reduced 13.21%	194,545 $31.5 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $3.65 Million - $4.39 Million	27,579 Added 14.03%	224,161 $35.7 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $1.2 Million - $1.58 Million	11,675 Added 6.31%	196,582 $26.6 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $4.65 Million - $5.7 Million	48,787 Added 35.84%	184,907 $18.4 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $1.53 Million - $1.81 Million	-14,827 Reduced 9.82%	136,120 $15.2 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $531,601 - $642,603	5,710 Added 3.93%	150,947 $16.8 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $2.91 Million - $3.55 Million	30,307 Added 26.37%	145,237 $16.3 Million
Q3 2021 Nov 16, 2021	BUY	$84.42 - $106.62 $216,874 - $273,906	2,569 Added 2.29%	114,930 $11 Million
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $586,747 - $735,038	-8,672 Reduced 7.16%	112,361 $9.41 Million
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $868,225 - $981,641	-12,947 Reduced 9.66%	121,033 $8.16 Million
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $6.75 Million - $7.79 Million	105,591 Added 371.94%	133,980 $9.36 Million
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $53,818 - $59,335	845 Added 3.07%	28,389 $1.97 Million
Q2 2020 Aug 19, 2020	BUY	$58.54 - $67.94 $1.61 Million - $1.87 Million	27,544 New	27,544 $1.8 Million
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $1.66 Million - $1.93 Million	-28,357 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $1.04 Million - $1.36 Million	21,066 Added 288.93%	28,357 $1.71 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $271,387 - $317,109	5,443 Added 294.53%	7,291 $422,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $76,765 - $87,318	1,848 New	1,848 $85,000
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $494,598 - $593,028	-10,200 Closed	0 $0
Q2 2017 Mar 19, 2018	BUY	N/A	10,200	10,200 $437,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gqg Partners LLC with notifications on news.

Account